Incomplete Atypical Femoral Fractures: Assessing the Diagnostic Utility of DXA by Extending Femur Length

Journal of Clinical Densitometry

Volumn 16, Issue 4, 2013, Pages 579-583

  McKenna, Malachi J ^a,b   van der Kamp, Susan ^a   Heffernan, Eric ^a,b   Hurson, Conor ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Atypical femoral fracture; Bisphosphonate; DXA

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; IBANDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; ATYPICAL FEMORAL FRACTURE; BONE DENSITY; BONE RADIOGRAPHY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEASIBILITY STUDY; FEMALE; FEMUR; FEMUR FRACTURE; HUMAN; INTRAMEDULLARY NAIL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PERIOSTEUM; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ATYPICAL FEMORAL FRACTURE; BISPHOSPHONATE; DXA;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; FEMALE; FEMORAL FRACTURES; FEMUR; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84887015791     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2013.06.004     Document Type: Article

References (16)

1. Odvina C.V., Zerwekh J.E., Rao D.S., et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005, 90:1294-1301.
2. Goh S.K., Yang K.Y., Koh J.S., et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. JBone Joint Surg Br 2007, 89:349-353.
3. Shane E., Burr D., Ebeling P.R., et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. JBone Miner Res 2010, 25:2267-2294.
4. McKiernan F.E. Atypical femoral diaphyseal fractures documented by serial DXA. J Clin Densitom 2010, 13:102-103.
5. McKiernan F.E., Hocking J., Cournoyer S., et al. A long femur scan field does not alter proximal femur bone mineral density measurements by dual-energy X-ray absorptiometry. J Clin Densitom 2011, 14:354-358.
6. McKenna M.J., van der Kamp S., Au-Yeong M., FitzGerald O. Improving standards of DXA. Ir Med J 2008, 101:101-102.
7. Looker A.C., Wahner H.W., Dunn W.L., et al. Proximal femur bone mineral levels of US adults. Osteoporos Int 1995, 5:389-409.
8. Prater G., Jankowski L., Peace F., et al. The effect of extending femur length on bone mineral density results on the Hologic Discovery-W scanner. J Clin Densitom 2013, 16(3):271-272.
9. Schilcher J., Michaelsson K., Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011, 364:1728-1737.
10. Koeppen V.A., Schilcher J., Aspenberg P. Atypical fractures do not have a thicker cortex. Osteoporos Int 2012, 23:2893-2896.
11. Meier R.P., Perneger T.V., Stern R., et al. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med 2012, 172:930-936.
12. Schilcher J., Koeppen V., Ranstam J., et al. Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone 2013, 52:389-392.
13. Babbie E. The practice of social research 2010, Wadsworth, Belmont, CA.
14. Feldstein A.C., Black D., Perrin N., et al. Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res 2012, 27:977-986.
15. Dell R.M., Adams A.L., Greene D.F., et al. Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 2012, 27:2544-2550.
16. Shane E., Ebeling P.R., Abrahamsen B., et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American society for bone and mineral research. J Bone Miner Res 2013, 2013 May 28. doi: 10.1002/jbmr.1998. [Epub ahead of print].